All In Biotech

Free tool

FAERS Monitor: Azelex

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 020428 or its brand name (Azelex, Azelaic Acid). Reports on generic versions are filed under their own applications.

Reports

977

Serious

510

52% of reports

Hospitalization

192

Death reported

86

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective172
  • pain142
  • off label use125
  • vomiting113
  • abdominal pain upper111
  • rash108
  • product use in unapproved indication107
  • gastrooesophageal reflux disease104
  • migraine104
  • paraesthesia103
  • memory impairment100
  • hypoaesthesia99
  • blepharospasm95
  • taste disorder93
  • drug intolerance91

Reports by year received

View as table
YearReports
20045
20051
20063
20071
20087
20099
201015
20116
201218
201310
201415
201527
201629
201719
201830
201939
202065
202180
202270
202388
2024139
2025146
2026155

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,182 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
blepharospasmSignal95329.7271.930,344
taste disorderSignal9399.181.78,904
gastrooesophageal reflux diseaseSignal10427.823.22,672
migraineSignal10423.519.62,223
drug intoleranceSignal9120.316.71,656
memory impairmentSignal10015.713.01,368
hypoaesthesiaSignal9914.211.81,214
paraesthesiaSignal10314.111.71,249
abdominal pain upperSignal11111.69.71,076
product use in unapproved indicationSignal1079.37.8793
rashSignal1085.34.5384
vomitingSignal1135.24.4385
painSignal1425.04.3461
off label useSignal1253.12.6180
drug ineffectiveSignal1722.82.5212

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.